Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19.

Kangro, Kadri; Wolberg, Alisa S; Flick, Matthew J

Kangro, Kadri; Wolberg, Alisa S; Flick, Matthew J.

Afiliación

Kangro K; Department of Pathology and Laboratory Medicine, UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Wolberg AS; Department of Pathology and Laboratory Medicine, UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Flick MJ; Department of Pathology and Laboratory Medicine, UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Curr Drug Targets ; 23(17): 1593-1602, 2022.

Article en En | MEDLINE | ID: mdl-36029073

Asunto(s)

COVID-19; Productos de Degradación de Fibrina-Fibrinógeno; Humanos; Fibrinógeno; Fibrina; Pandemias; SARS-CoV-2

Palabras clave

COVID-19; D-dimer; Fibrinogen; coagulation; fibrin; fibrinolysis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos de Degradación de Fibrina-Fibrinógeno / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google